BreakBio's uses new technologies to cure cancer. It starts with colorectal cancer, the 2nd highest cause of cancer death. The FDA can offer Breakthrough Therapy Designation (BTD) as an incentive to investors.

It will also prevent cancers for those at risk- an enormous market.

BreakBio’s AI software finds many proteins to target on each patient's cancer cells: the dawn of AI drug design per patient and personalized drug manufacture per patient.